Ep 274 - Medtronic Neuro’s New CMO seeks impact over intimacy; Anteris' CEO lays out the path forward

In this week’s episode of DeviceTalks Weekly, neurosurgeon Adam Arthur, MD, explains why he’s trading surgical scrubs for the chance to help lead Medtronic’s Neurovascular business as its new chief medical officer. Dr. Arthur joins Host Tom Salemi to discuss how neurosurgery is reaching more patients today—and what it must do to expand its impact in the years ahead. Before the keynote interview, Managing Editor Kayleen Brown speaks with Brittany Mai of Confluent Medical Technologies about the future of neuro and minimally invasive surgery. Thank you to Confluent for sponsoring this week’s episode. Learn more at ConfluentMedical.com. At the top of the show, MassDevice Editor Chris Newmarker talks with Wayne Paterson, CEO of Anteris Technologies, about the company’s new agreement with Medtronic and what it means for the future of TAVR. Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:03:38) - Chris Newmarker interviews Wayne Paterson, CEO of Anteris Technologies(00:06:10) - This is not your Father’s TAVR(00:08:00) - Terms of the Medtronic investment(00:25:30) - Kayleen Brown sits down with Brittany Mai of Confluent Medical(00:29:50) - How is minimally invasive technology changing?(00:31:28) - Keynote conversation – Adam Arthur, MD, new chief medical officer for Medtronic Neurovascular(00:35:30) - What makes a good neurosurgeon?(00:39:01) - Choosing impact over intimacy(00:44:50) - What do patients fear more than death?(00:49:45) - More focus needed on Women’s neurological health including chronic refractory migraine